HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.

AbstractPURPOSE:
PCK3145 is an anti-metastatic synthetic peptide with promising therapeutic efficacy against hormone-refractory prostate cancer. The characterization of the PCK3145 peptide cell surface binding/internalization mechanisms and of the receptors involved remained to be explored.
RESULTS:
[(14)C]PCK3145 cell surface binding assays showed rapid and transient kinetic profile, that was inhibited by RGD peptides, laminin, hyaluronan, and type-I collagen. RGD peptides were however unable to inhibit PCK3145 intracellular uptake. Far-Western ligand binding studies enabled the identification of the 37-kDa laminin receptor precursor (37LRP) as a potential ligand for PCK3145. Overexpression of the recombinant 37LRP indeed led to an increase in PCK3145 binding but unexpectedly not to its uptake.
CONCLUSIONS:
Our data support the implication of laminin receptors in cell surface binding and in transducing PCK3145 anti-metastatic effects, and provide a rational for targeting cancers that express high levels of such laminin receptors.
AuthorsBorhane Annabi, Jean-Christophe Currie, Mounia Bouzeghrane, Hélène Dulude, Luc Daigneault, Seema Garde, Shafaat A Rabbani, Chandra Panchal, Jinzi J Wu, Richard Béliveau
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 346 Issue 1 Pg. 358-66 (Jul 21 2006) ISSN: 0006-291X [Print] United States
PMID16759641 (Publication Type: Journal Article)
Chemical References
  • Collagen Type I
  • Oligopeptides
  • Peptide Fragments
  • Prostatic Secretory Proteins
  • Protein Precursors
  • Receptors, Cell Surface
  • Receptors, Laminin
  • tigapotide
  • arginyl-glycyl-aspartic acid
  • Catechin
  • epigallocatechin gallate
  • Matrix Metalloproteinase 9
Topics
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Communication
  • Cell Line, Tumor
  • Collagen Type I (pharmacology)
  • Drug Synergism
  • Humans
  • Kinetics
  • Matrix Metalloproteinase 9 (metabolism)
  • Neoplasm Metastasis (drug therapy)
  • Oligopeptides (pharmacology)
  • Peptide Fragments (metabolism)
  • Prostatic Secretory Proteins (metabolism)
  • Protein Precursors (metabolism)
  • Receptors, Cell Surface (metabolism)
  • Receptors, Laminin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: